Cardiovascular Complications in Patients with HIV Infection

Area of Science:

• Cardiology
• Infectious Diseases
• Public Health

Background:

• Improved survival in HIV infection due to advances in diagnosis, therapy, and supportive care.
• Increased prevalence of cardiac abnormalities in the growing population of HIV-infected patients.
• Common cardiovascular manifestations include dilated cardiomyopathy, myocarditis, pericardial effusion, endocarditis, pulmonary hypertension, and drug-related cardiotoxicity.

Purpose of the Study:

• To review the principal cardiovascular manifestations associated with HIV disease.
• To highlight new knowledge regarding the prevalence, pathogenesis, and treatment of HIV-related cardiac conditions.
• To discuss the impact of highly active antiretroviral therapy (HAART) on cardiovascular health in HIV patients.

Main Methods:

• Literature review of HIV-associated cardiovascular manifestations.
• Analysis of current data on prevalence and pathogenesis.
• Synthesis of information on treatment strategies.

Main Results:

• HIV infection presents with diverse cardiac issues, including cardiomyopathy, myocarditis, and pulmonary hypertension.
• Highly active antiretroviral therapy (HAART) has improved HIV patient survival and quality of life.
• Concerns exist regarding a potential increase in peripheral and coronary arterial disease associated with HAART.

Conclusions:

• HIV-infected patients face significant cardiovascular risks requiring ongoing monitoring and management.
• Understanding the evolving landscape of HIV-associated cardiovascular disease is crucial for effective patient care.
• Further research is needed to fully elucidate the long-term cardiovascular effects of HAART and inform treatment guidelines.